enVVeno Medical Corp. is a development stage medical device company, which develops tissue based solutions that are designed to be life sustaining or life enhancing for patients with cardiovascular disease, and peripheral arterial and venous disease. Its products include VenoValve and enVVe. The company was founded by Norman Jaffe on December 22, 1999 and is headquartered in Irvine, CA.
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. enVVeno Medical Corporation market cap is $4.29M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. enVVeno Medical Corporation 52 week high is $14.67 as of November 15, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. enVVeno Medical Corporation 52 week low is $6.14 as of November 15, 2026.
enVVeno Medical Corporation stock price today is $6.17.
enVVeno Medical Corporation stock price yesterday was $6.58.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. enVVeno Medical Corporation's P/E ratio is -0.26.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. enVVeno Medical Corporation P/B ratio is 0.2537.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. enVVeno Medical Corporation 50-day moving average is $8.11.
